Mayo Clinic Plans 2012 Launch for Sequencing-Based Colon Cancer Panel

Like other pioneers in sequencing-based diagnostics, the Mayo team is grappling with questions such as how to deal with mutations of unknown significance, how to return results to patients, and whether results need to be verified with Sanger sequencing.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.